NCAB Discusses Future of Cancer Technology at NCI
"There is an extraordinary evolution going on in biomedical technology," said Dr. Eric Lander, co-chair with Dr. Leland Hartwell of the National Cancer Advisory Board (NCAB) ad hoc Subcommittee on Biomedical Technology Working Group, as he began his presentation at the Board's meeting on September 14. Dr. Lander discussed the Working Group's 2004 agenda, which focused on specific ways to take advantage of the potential power of technology through projects, initiatives, and structures that would have an effect all across cancer.
The NCAB Biomedical Technology Subcommittee established the Working Group to advise the Board, National Cancer Institute (NCI) Director Dr. Andrew C. von Eschenbach, and senior leadership on the development and application of biomedical technologies to cancer. Before this meeting, the Working Group enlisted the help of outside experts and developed subgroups to examine specific aspects and themes related to cancer and advancing technologies. Read more
Communication: An Important Cornerstone of Success
Last week NCI released its inaugural annual report, The Nation's Progress in Cancer Research for 2003, available at www.cancer.gov/aboutnci/annualreport. This new communication tool describes some of the successes from NCI-supported research published in late 2002 and 2003 - highlights that are representative of the discovery, development, and delivery continuum and illustrate the progress we are making toward the 2015 goal.
The development of an annual report is just one example of the evolution of how NCI communicates with its key constituencies, including the public. We have reached a crossroads in the battle against cancer, so it is vital that we communicate effectively with all of our stakeholders to provide evidence-based guidance and inform them about the latest happenings that affect their lives.
NCI's communication strategy is based on a two-pronged approach: first, we proactively disseminate information on current NCI initiatives, breaking cancer news, and other cancer topics. We are also prepared, however, to react and respond to scientific and programmatic issues as they arise. Read more